High-throughput genotyping assays for identification of glycophorin B deletion variants in population studies
Open Access
- 16 December 2020
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 246 (8) , 916-928
Abstract
Glycophorins are the most abundant sialoglycoproteins on the surface of human erythrocyte membranes. Genetic variation in glycophorin region of human chromosome 4 (containing GYPA, GYPB, and GYPE genes) is of interest because the gene products serve as receptors for pathogens of major public health interest, including Plasmodium sp., Babesia sp., Influenza virus, Vibrio cholerae El Tor Hemolysin, and Escherichia coli. A large structural rearrangement and hybrid glycophorin variant, known as Dantu, which was identified in East African populations, has been linked with a 40% reduction in risk for severe malaria. Apart from Dantu, other large structural variants exist, with the most common being deletion of the whole GYPB gene and its surrounding region, resulting in multiple different deletion forms. In West Africa particularly, these deletions are estimated to account for between 5 and 15% of the variation in different populations, mostly attributed to the forms known as DEL1 and DEL2. Due to the lack of specific variant assays, little is known of the distribution of these variants. Here, we report a modification of a previous GYPB DEL1 assay and the development of a novel GYPB DEL2 assay as high-throughput PCR-RFLP assays, as well as the identification of the crossover/breakpoint for GYPB DEL2. Using 393 samples from three study sites in Ghana as well as samples from HapMap and 1000 G projects for validation, we show that our assays are sensitive and reliable for genotyping GYPB DEL1 and DEL2. To the best of our knowledge, this is the first report of such high-throughput genotyping assays by PCR-RFLP for identifying specific GYPB deletion types in populations. These assays will enable better identification of GYPB deletions for large genetic association studies and functional experiments to understand the role of this gene cluster region in susceptibility to malaria and other diseases.Keywords
Funding Information
- The Wellcome Trust (Wellcome (090770/Z/09/Z; 204911/Z/16/Z: Kwiatkowsk, Wellcome (107755/Z/15/Z: Awandare))
- The Developing Excellence in Leadership, Training and Science (DELTAS), African Academy of Sciences (AAS)’s Alliance for Accelerating Excellence in Science in Africa (DELTAS Africa grant (DEL-15-007: Awandare))
This publication has 35 references indexed in Scilit:
- The distribution of haemoglobin C and its prevalence in newborns in AfricaScientific Reports, 2013
- Gene Conversion in Human Genetic DiseaseGenes, 2010
- Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesisNature Communications, 2010
- Complement receptor 1 is the host erythrocyte receptor forPlasmodium falciparumPfRh4 invasion ligandProceedings of the National Academy of Sciences, 2010
- Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1Proceedings of the National Academy of Sciences, 2009
- Invasion of Red Blood Cells by Malaria ParasitesCell, 2006
- How Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about MalariaThe American Journal of Human Genetics, 2005
- Both heterozygous and homozygous α+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of KenyaBlood, 2005
- A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2-3)Gal- sequences of glycophorin A.Journal of Cell Biology, 1992
- PREPARATION OF AN INHIBITOR OF VIRAL HEMAGGLUTINATION FROM HUMAN ERYTHROCYTESJournal of Experimental Medicine, 1961